← Eichor
Study identifier: NCT07203092 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Transcranial Photobiomodulation in ADHD

Condition: Attention Deficit Hyperactivity Disorder  ·  Sponsor: Francisco Gonzalez-Lima, PhD

PhaseNA
Planned participants140
Who can joinAll sexes, 18 Years to 44 Years
Healthy volunteersNo

About this study

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Francisco Gonzalez-Lima, Ph.D.  ·  512-537-5257  ·  UTBrainProject@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas at AustinAustin, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07203092